Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations

Canada’s obligations under the North American Free Trade Agreement and the Agreement on Trade-Related Aspects of Intellectual Property Rights require the granting of protection for undisclosed test or other data necessary to determine the safety and effectiveness of a pharmaceutical product which utilizes a new chemical entity, the origination of which involved considerable effort.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ligne directrice : La protection des données en vertu de l'article C.08.004.1 du Règlement sur les aliments et drogues [Santé Canada, 2010]
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2011-10-07 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Protection des données", "Règlement sur les aliments et drogues", "Accord de libre-échange nord-américain", "accord", "commerce", "droits de propriété intellectuelle", "test non divulgué", "sécurité et efficacité", "produit pharmaceutique", "nouvelle entité chimique"], "en": ["Data protection", "Food and Drug Regulations", "North American Free Trade Agreement", "agreement", "trade", "intellectual property rights", "undisclosed test", "safety and effectiveness", "pharmaceutical product", "a new chemical entity"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source